Daxor Corporation (DXR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Daxor Corporation (DXR) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($467.04K) by net assets ($35.63 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Daxor Corporation - Cash Flow Conversion Efficiency Trend (1985–2024)
This chart illustrates how Daxor Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Daxor Corporation (DXR) total liabilities for a breakdown of total debt and financial obligations.
Daxor Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Daxor Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
JLS Co.Ltd
KQ:040420
|
0.043x |
|
Chang Ho Fibre Corp
TW:1468
|
0.022x |
|
Facephi Biometria SA
MC:FACE
|
0.035x |
|
Charm Engine
KO:009310
|
2.160x |
|
Shagrir Group Vehicle Services Ltd
TA:SHGR
|
0.072x |
|
Shan-Loong Transportation Co Ltd
TW:2616
|
-0.011x |
|
Globaltec Formation Bhd
KLSE:5220
|
0.056x |
|
ATrack Technology
TWO:6465
|
-0.024x |
Annual Cash Flow Conversion Efficiency for Daxor Corporation (1985–2024)
The table below shows the annual cash flow conversion efficiency of Daxor Corporation from 1985 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Daxor Corporation worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $35.79 Million | $25.69K | 0.001x | +100.67% |
| 2023-12-31 | $34.01 Million | $-3.66 Million | -0.107x | -304.70% |
| 2022-12-31 | $28.97 Million | $-769.30K | -0.027x | +79.64% |
| 2021-12-31 | $21.15 Million | $-2.76 Million | -0.130x | +16.47% |
| 2020-12-31 | $15.68 Million | $-2.45 Million | -0.156x | -164.05% |
| 2019-12-31 | $12.77 Million | $3.11 Million | 0.244x | +342.04% |
| 2018-12-31 | $13.06 Million | $-1.32 Million | -0.101x | -18.18% |
| 2017-12-31 | $13.76 Million | $-1.17 Million | -0.085x | -182.11% |
| 2016-12-31 | $15.34 Million | $1.59 Million | 0.104x | -91.92% |
| 2015-12-31 | $14.43 Million | $18.53 Million | 1.284x | +10776.23% |
| 2014-12-31 | $24.58 Million | $-295.64K | -0.012x | +96.49% |
| 2013-12-31 | $26.37 Million | $-9.04 Million | -0.343x | -368.80% |
| 2012-12-31 | $35.11 Million | $4.48 Million | 0.128x | +170.98% |
| 2011-12-31 | $36.22 Million | $-6.51 Million | -0.180x | -48.43% |
| 2010-12-31 | $47.00 Million | $-5.69 Million | -0.121x | -9.77% |
| 2009-12-31 | $47.63 Million | $-5.25 Million | -0.110x | -18.67% |
| 2008-12-31 | $43.46 Million | $-4.04 Million | -0.093x | -62.40% |
| 2007-12-31 | $54.92 Million | $-3.14 Million | -0.057x | +24.08% |
| 2006-12-31 | $45.64 Million | $-3.44 Million | -0.075x | -152.57% |
| 2005-12-31 | $38.74 Million | $-1.16 Million | -0.030x | +34.97% |
| 2004-12-31 | $39.88 Million | $-1.83 Million | -0.046x | -51.31% |
| 2003-12-31 | $36.42 Million | $-1.10 Million | -0.030x | -378.23% |
| 2002-12-31 | $33.55 Million | $-212.77K | -0.006x | -201.10% |
| 2001-12-31 | $35.33 Million | $221.63K | 0.006x | +327.81% |
| 2000-12-31 | $38.67 Million | $-106.49K | -0.003x | +82.89% |
| 1999-12-31 | $29.28 Million | $-471.20K | -0.016x | +28.99% |
| 1998-12-31 | $35.30 Million | $-800.00K | -0.023x | -286.40% |
| 1997-12-31 | $32.90 Million | $400.00K | 0.012x | +93.31% |
| 1996-12-31 | $31.80 Million | $200.00K | 0.006x | -32.70% |
| 1995-12-31 | $32.10 Million | $300.00K | 0.009x | -70.93% |
| 1994-12-31 | $31.10 Million | $1.00 Million | 0.032x | -39.65% |
| 1993-12-31 | $24.40 Million | $1.30 Million | 0.053x | -48.34% |
| 1992-12-31 | $22.30 Million | $2.30 Million | 0.103x | +64.16% |
| 1991-12-31 | $19.10 Million | $1.20 Million | 0.063x | -42.64% |
| 1990-12-31 | $21.00 Million | $2.30 Million | 0.110x | +509.62% |
| 1989-12-31 | $18.70 Million | $-500.00K | -0.027x | -114.94% |
| 1988-12-31 | $19.00 Million | $3.40 Million | 0.179x | +59.93% |
| 1986-12-31 | $14.30 Million | $1.60 Million | 0.112x | -19.81% |
| 1985-12-31 | $12.90 Million | $1.80 Million | 0.140x | -- |
About Daxor Corporation
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corpo… Read more